Gain instant access to the most up-to-date information on the diabetes market. Scour in-depth profiles of brands and diabetes drug makers to target and seize market share, optimise return on investment, prove the value of your assets, and set proactive brand strategies.

In addition to market forecasts, you’ll find primary data from physicians worldwide as well as industry leaders in R&D and marketing. Their input provides knowledgeable, fresh insights on emerging treatments and unmet needs in the diabetes space.

patent information and clinical data

Save money and valuable time with sales projections, patent information and clinical data – all in context, so you can compare brands, classes and companies.

Answer critical questions about your diabetes portfolio:

  • Are you entering the diabetes market – or expanding your current portfolio?
  • How does your developing drug compare to brands on the market? Does your drug stand a chance?
  • Are you working on another DPP-4 inhibitor or GLP-1 analog – and ignoring a market push toward novel therapies?
  • Have you been hit by the FDA’s cardiovascular guidelines? Are you adequately prepared for regulatory review?
  • Are you trying to out-license a diabetes product?
  • How will your early-stage diabetes compound fare in tomorrow’s market? Is there room for your drug, too?

To download a summary of the report click here and to purchase the full report please click here.